Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REALISE
PACTR202402529220760Phase 3Not yet recruiting
- Sponsor
- Laboratorios Liconsa
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, open-label trial of albendazole and ivermectin in Soil-Transmitted Helminthiases (STH) and trichuriasis (2 arms), sponsored by Laboratorios Liconsa. Primary endpoint: Frequency, type and severity of related adverse events and serious adverse events. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
albendazoleivermectin
03
Conditions
Soil-Transmitted Helminthiases (STH)trichuriasis
Beyond the preview
Go deeper on PACTR202402529220760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202402529220760.